title: VLA-5 in the plasma cell line, FR4ds, acts as a common regulator of VLA-4 and VLA-6 in spreading induced by fibronectin and laminin.
abstract: VLA-5 recognizes the GRGDSP sequence of fibronectin (FN) in the extracellular matrix (ECM). We examined the role of beta1 integrin in the spreading of the human plasma cell line, FR4ds, induced by FN and laminin (LN). We first examined the role of VLA-5 in the spreading induced by FN. Anti-alpha4 antibody induced 46.4% inhibition, whereas anti-alpha5 had no effect. A combination of anti-alpha4 and anti-alpha5 enhanced the inhibition of spreading significantly. Complementary inhibition was also demonstrated using the GRGDSP peptide plus anti-alpha4 and the GRGDNP peptide of LN plus anti-alpha4. The results suggested that VLA-5 is a regulator of VLA-4 and that it is involved in the recognition of GRGDNP. We then examined the role of VLA-5 in the spreading induced by LN. Anti-alpha6 induced 53.1% inhibition. Anti-alpha5 alone had no effect. A combination of alpha5 and anti-alpha6, however, significantly enhanced the inhibition of spreading. The combination of GRGDSP plus anti-alpha6 and GRGDNP plus anti-alpha6 resulted in complete inhibition. These results suggested that VLA-5 participates in the recognition of LN cooperatively with VLA-6 and that VLA-5 is a common regulator of VLA-4 and the LN receptor, VLA-6.
authors.affiliation: Department of Hematology and Oncology, Osaka University Medical School, Suita, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Hattori
authors.forename: S
authors.initials: S
authors.lastname: Tagawa
authors.forename: H
authors.initials: H
authors.lastname: Shibayama
authors.forename: R
authors.initials: R
authors.lastname: Inoue
authors.forename: S
authors.initials: S
authors.lastname: Katagiri
authors.forename: T
authors.initials: T
authors.lastname: Machii
authors.forename: T
authors.initials: T
authors.lastname: Kitani
mesh_terms: D002465:Cell Movement / Q000187:drug effects; D005353:Fibronectins / Q000494:pharmacology*; D006801:Humans; D039041:Integrin alpha4beta1; D039121:Integrin alpha6beta1; D016023:Integrins / Q000502:physiology*; D007797:Laminin / Q000494:pharmacology*; D009842:Oligopeptides / Q000494:pharmacology; D010950:Plasma Cells / Q000166:cytology / Q000502:physiology*; D017469:Receptors, Fibronectin / Q000276:immunology / Q000502:physiology*; D017474:Receptors, Laminin / Q000276:immunology / Q000502:physiology; D016201:Receptors, Lymphocyte Homing / Q000502:physiology*; D014407:Tumor Cells, Cultured
chemical_list: D005353:Fibronectins; D039041:Integrin alpha4beta1; D039121:Integrin alpha6beta1; D016023:Integrins; D007797:Laminin; D009842:Oligopeptides; D017469:Receptors, Fibronectin; D017474:Receptors, Laminin; D016201:Receptors, Lymphocyte Homing; C047981:arginyl-glycyl-aspartic acid; C058161:glycyl-arginyl-glycyl-aspartyl-seryl-proline